In ovarian cancer and triple-negative breast cancer, tumor cells evade clearance by macrophages through over-expression of CD24 that interacts with Siglec-10 in TAMs, and its blockade augments the phagocytosis of CD24-expressing tumors leading to a reduction of tumor growth (78). Here, CD24 is linked to ovarian cancer.